Synthetic Biologics (SYN) News Today → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free SYN Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 12:43 PM | msn.comStages of Rheumatoid ArthritisMay 15 at 12:43 PM | benzinga.comThe Analyst Verdict: Absci In The Eyes Of 6 ExpertsMay 14, 2024 | seekingalpha.comHumacyte: A Strong Opportunity In Wound Healing - A 'Buy' Before Price Gets Too HighMay 14, 2024 | tmcnet.comNabla Bio Secures $26M Series A Financing and Collaborations with AstraZeneca, Bristol Myers Squibb and Takeda for Generative Protein DesignMay 12, 2024 | msn.comSangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call TranscriptMay 9, 2024 | finance.yahoo.comAqtual to Present Data on Innovative Approach to Rheumatoid Arthritis Therapy Selection at CCR East 2024May 2, 2024 | finance.yahoo.comPeptide Synthesis: Global Markets Projected to Reach $157.5 Billion by 2028, According to BCC Research AnalysisApril 30, 2024 | finance.yahoo.comSphere Fluidics Appoints Dale Levitzke as Chief Executive OfficerApril 30, 2024 | finance.yahoo.comEnlaza Therapeutics Raises $100 Million through Its Series A Financing, Led by the Life Sciences Group of J.P. Morgan Private CapitalApril 29, 2024 | finance.yahoo.comNavigating the Dynamic Landscape of CMO/CDMO Services Market in Today's Pharma Industry; Report by TNR, The Niche ResearchApril 26, 2024 | finance.yahoo.comRegenerative Medicine Market Size Expected to Reach USD 154.05 Bn by 2033April 24, 2024 | finance.yahoo.comGenScript Singapore's Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug DiscoveryApril 23, 2024 | finance.yahoo.comActive Pharmaceutical Ingredient Market Trends Signal Growth Towards USD 446.6 Billion by 2032 With CAGR AT 6.4%April 23, 2024 | markets.businessinsider.comTheriva Biologics Announces Positive Data From Phase 1 Trial Of VCN-01 In Intraocular RetinoblastomaApril 22, 2024 | msn.comElon Musk rejects Tucker Carlson’s viral alien conspiracy theoryApril 19, 2024 | markets.businessinsider.comAziyo Biologics Poised for Growth: Buy Rating Affirmed Amidst Anticipated FDA Clearance and Strong Financial OutlookApril 17, 2024 | finance.yahoo.comX-Therma Announces XT-Thrive® Drug Master File (DMF) Accepted by U.S. Food and Drug Administration (FDA)April 17, 2024 | finance.yahoo.comMustGrow Biologics to Present at the Planet MicroCap ShowcaseApril 10, 2024 | msn.com31 Netizens Share What They Consider To Be Next Big Changes In The Culture Of The InternetApril 7, 2024 | businesswire.comAffini-T Therapeutics Presents Preclinical Data from its Oncogenic Driver Programs Targeting KRAS G12D and p53 R175H at the American Association for Cancer Research (AACR ...April 3, 2024 | finance.yahoo.comSix Arizona Startups Driving Biosciences Forward in 2024April 2, 2024 | finance.yahoo.comRetinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsightApril 2, 2024 | tmcnet.comBCC Research Reveals Top Ten Suppliers of Synthetic Biology Technology in 2024March 30, 2024 | finance.yahoo.comPharmaceutical Membrane Filtration Market is Expected to Reach $19.6 billion | MarketsandMarkets™March 27, 2024 | markets.businessinsider.comBuy Recommendation for Theriva Biologics Backed by Promising Oncolytic Adenovirus Platform and Clinical Trial AdvancementsMarch 26, 2024 | msn.comWhy Is Your Pubic Hair Itchy—and How Can You Treat It?March 25, 2024 | msn.comUpdated recommendations for psoriatic arthritisMarch 23, 2024 | msn.comHumacyte, Inc. (NASDAQ:HUMA) Q4 2023 Earnings Call TranscriptMarch 22, 2024 | markets.businessinsider.com6 Analysts Assess Absci: What You Need To KnowMarch 19, 2024 | msn.comSamsung Life Science Fund invests in Massachusetts-based BrickBioMarch 18, 2024 | yahoo.comWhat Is Pustular Psoriasis?March 18, 2024 | finance.yahoo.comGRO Biosciences Expands Executive Team with Appointment of Biopharma Veteran Tracey Lodie, PhD as Chief Development OfficerMarch 18, 2024 | finance.yahoo.comSamsung Invests in BrickBio to Develop Advanced Molecules and Therapies Using Protein Engineering Technology for Antibody-Drug Conjugates (ADC)March 17, 2024 | usnews.comBlinken Calls for Closer Global Cooperation on Tackling Synthetic DrugsMarch 14, 2024 | finance.yahoo.comAgricultural Biologicals Market Analysis Report 2024-2030 - Market to Reach USD 12.62 Billion by 2030, Asia-Pacific to Exhibit Rapid GrowthMarch 14, 2024 | msn.comAfter 50 years, Tommy John surgery is evolving to increase success and sometimes speed returnMarch 12, 2024 | finanznachrichten.deGenScript Biotech Corporation: GenScript Biotech Announces 2023 Annual Results with a Five-Year CAGR stands at 30%March 12, 2024 | finance.yahoo.comPearl Bio Inks Collaboration with Merck to Discover Novel Engineered BiologicsMarch 7, 2024 | msn.comOrthofix Medical Inc. (NASDAQ:OFIX) Q4 2023 Earnings Call TranscriptMarch 7, 2024 | finance.yahoo.comSurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone GraftMarch 6, 2024 | markets.businessinsider.comThe Analyst Landscape: 4 Takes On AbsciFebruary 29, 2024 | theglobeandmail.com3 AI-Driven Drug Stocks to Buy Before They BreakoutFebruary 29, 2024 | msn.comHow to manage eczema – according to a dermatologistFebruary 29, 2024 | bizjournals.comBayer, AgStart launch competition to find ag and food startups that need free lab spaceFebruary 28, 2024 | finance.yahoo.combit.bio Announced as Inaugural Partner of Ginkgo Bioworks’ New Technology NetworkFebruary 26, 2024 | theglobeandmail.comShort sales on the TSX: What bearish investors are betting againstFebruary 25, 2024 | msn.comTwist Bioscience (TWST) Price Target Increased by 19.85% to 41.57February 23, 2024 | msn.comYour Guide To Axial Spondyloarthritis TreatmentsFebruary 15, 2024 | finanznachrichten.deNurExone Biologic Inc: NurExone Launches Licensing Efforts for ExoTherapy PlatformFebruary 14, 2024 | axios.comGroup hits lone Democrat over drug pricing bill Get Synthetic Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for SYN and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. SYN Media Mentions By Week SYN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SYN News Sentiment▼0.580.50▲Average Medical News Sentiment SYN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SYN Articles This Week▼53▲SYN Articles Average Week Get Synthetic Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for SYN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Vincerx Pharma News Flora Growth News Oncotelic Therapeutics News NeuroSense Therapeutics News Tonix Pharmaceuticals News Ceapro News Talphera News Minerva Neurosciences News GlycoMimetics News Edesa Biotech News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:SYN) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubThe Presidential candidate you should REALLY be worried aboutStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synthetic Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
